ClinicalTrials.gg

Drug class

Antifibrinolytic Agents clinical trials

A class of medicines: the studies that test any of its 4 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it
668
open now
128
in phase 3
161
first study started
2000

Keep track of what changes. Save the antifibrinolytic agents studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Studies by the year they started

665 studies that test it; most in 2021 (54); 2 more planned to start later

Studies that test Antifibrinolytic Agents, by start year
YearStudies
20001
20011
20021
20033
20042
20056
200610
20072
200811
200914
201015
201114
201223
201329
201433
201538
201641
201729
201850
201942
202047
202154
202246
202344
202438
202537
202634

By phase

A phase 1/2 study counts in both.

Early Phase 1
23
Phase 1
30
Phase 2
105
Phase 3
161
Phase 4
210
No phase
179

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 24 · Other 644

Cairo University (20) · Assiut University (20) · Aswan University Hospital (12) · Ain Shams University (11) · London School of Hygiene and Tropical Medicine (9) · NYU Langone Health (9) · Northwestern University (7) · Hospital for Special Surgery, New York (7)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.

Testing one of them · 668

See all 668 studies that test one of the antifibrinolytic agents →